CRANE CO (CR) Stock Fundamental Analysis
NYSE:CR - New York Stock Exchange, Inc. - US2244081046 - Common Stock - Currency: USD
Overall CR gets a fundamental rating of 6 out of 10. We evaluated CR against 128 industry peers in the Machinery industry. CR gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, CR is valued expensive at the moment. These ratings could make CR a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
CR had positive earnings in the past year.
In the past year CR had a positive cash flow from operations.
Each year in the past 5 years CR has been profitable.
CR had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CR's Return On Assets of 11.15% is amongst the best of the industry. CR outperforms 82.95% of its industry peers.
CR's Return On Equity of 17.98% is fine compared to the rest of the industry. CR outperforms 78.29% of its industry peers.
CR's Return On Invested Capital of 13.11% is amongst the best of the industry. CR outperforms 80.62% of its industry peers.
CR had an Average Return On Invested Capital over the past 3 years of 9.11%. This is in line with the industry average of 10.65%.
The 3 year average ROIC (9.11%) for CR is below the current ROIC(13.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.15% | ||
| ROE | 17.98% | ||
| ROIC | 13.11% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
1.3 Margins
CR has a Profit Margin of 13.83%. This is amongst the best in the industry. CR outperforms 85.27% of its industry peers.
In the last couple of years the Profit Margin of CR has grown nicely.
Looking at the Operating Margin, with a value of 16.69%, CR is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
In the last couple of years the Operating Margin of CR has grown nicely.
CR has a Gross Margin of 40.72%. This is in the better half of the industry: CR outperforms 75.97% of its industry peers.
CR's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.69% | ||
| PM (TTM) | 13.83% | ||
| GM | 40.72% |
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CR is creating some value.
Compared to 1 year ago, CR has more shares outstanding
The number of shares outstanding for CR has been reduced compared to 5 years ago.
Compared to 1 year ago, CR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 8.06 indicates that CR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.06, CR belongs to the top of the industry, outperforming 89.92% of the companies in the same industry.
The Debt to FCF ratio of CR is 1.06, which is an excellent value as it means it would take CR, only 1.06 years of fcf income to pay off all of its debts.
CR's Debt to FCF ratio of 1.06 is amongst the best of the industry. CR outperforms 86.05% of its industry peers.
CR has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
CR has a Debt to Equity ratio of 0.15. This is in the better half of the industry: CR outperforms 75.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.06 | ||
| Altman-Z | 8.06 |
ROIC/WACC1.3
WACC10.12%
2.3 Liquidity
A Current Ratio of 2.58 indicates that CR has no problem at all paying its short term obligations.
CR's Current ratio of 2.58 is fine compared to the rest of the industry. CR outperforms 67.44% of its industry peers.
CR has a Quick Ratio of 1.88. This is a normal value and indicates that CR is financially healthy and should not expect problems in meeting its short term obligations.
CR's Quick ratio of 1.88 is fine compared to the rest of the industry. CR outperforms 74.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
CR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.41%, which is quite impressive.
CR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.00% yearly.
The Revenue has grown by 14.45% in the past year. This is quite good.
Measured over the past years, CR shows a decrease in Revenue. The Revenue has been decreasing by -8.28% on average per year.
EPS 1Y (TTM)25.41%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.93%
Revenue 1Y (TTM)14.45%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.36%
3.2 Future
The Earnings Per Share is expected to grow by 12.23% on average over the next years. This is quite good.
CR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.72% yearly.
EPS Next Y9.69%
EPS Next 2Y11.12%
EPS Next 3Y11.07%
EPS Next 5Y12.23%
Revenue Next Year5.66%
Revenue Next 2Y6%
Revenue Next 3Y5.8%
Revenue Next 5Y6.72%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 31.51, CR can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CR is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of CR to the average of the S&P500 Index (28.18), we can say CR is valued inline with the index average.
CR is valuated quite expensively with a Price/Forward Earnings ratio of 26.36.
CR's Price/Forward Earnings ratio is in line with the industry average.
CR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.51 | ||
| Fwd PE | 26.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CR indicates a slightly more expensive valuation: CR is more expensive than 66.67% of the companies listed in the same industry.
CR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CR is more expensive than 61.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.43 | ||
| EV/EBITDA | 23.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CR does not grow enough to justify the current Price/Earnings ratio.
CR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.25
PEG (5Y)N/A
EPS Next 2Y11.12%
EPS Next 3Y11.07%
5. Dividend
5.1 Amount
CR has a yearly dividend return of 0.53%, which is pretty low.
CR's Dividend Yield is comparable with the industry average which is at 2.04.
Compared to an average S&P500 Dividend Yield of 2.45, CR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
The dividend of CR decreases each year by -12.19%.
CR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-12.19%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CR pays out 15.91% of its income as dividend. This is a sustainable payout ratio.
DP15.91%
EPS Next 2Y11.12%
EPS Next 3Y11.07%
167.93
+4.89 (+3%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners75.72%
Inst Owner Change0%
Ins Owners0.25%
Ins Owner Change0.55%
Market Cap9.65B
Analysts82.35
Price Target180.18 (7.29%)
Short Float %0.87%
Short Ratio1.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly Dividend0.82
Dividend Growth(5Y)-12.19%
DP15.91%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.91%
Min EPS beat(2)0.24%
Max EPS beat(2)1.58%
EPS beat(4)4
Avg EPS beat(4)2.2%
Min EPS beat(4)0.24%
Max EPS beat(4)5.25%
EPS beat(8)8
Avg EPS beat(8)11.04%
EPS beat(12)11
Avg EPS beat(12)8.45%
EPS beat(16)15
Avg EPS beat(16)12.28%
Revenue beat(2)0
Avg Revenue beat(2)-1.77%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-1.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)0.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)3.05%
Revenue beat(16)8
Avg Revenue beat(16)1.45%
PT rev (1m)-3.15%
PT rev (3m)-0.76%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)1.29%
EPS NY rev (1m)-0.75%
EPS NY rev (3m)-0.88%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.51 | ||
| Fwd PE | 26.36 | ||
| P/S | 4.53 | ||
| P/FCF | 41.43 | ||
| P/OCF | 35.8 | ||
| P/B | 5.89 | ||
| P/tB | 11.81 | ||
| EV/EBITDA | 23.58 |
EPS(TTM)5.33
EY3.17%
EPS(NY)6.37
Fwd EY3.79%
FCF(TTM)4.05
FCFY2.41%
OCF(TTM)4.69
OCFY2.79%
SpS37.08
BVpS28.51
TBVpS14.22
PEG (NY)3.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.15% | ||
| ROE | 17.98% | ||
| ROCE | 16.95% | ||
| ROIC | 13.11% | ||
| ROICexc | 15.36% | ||
| ROICexgc | 28.36% | ||
| OM | 16.69% | ||
| PM (TTM) | 13.83% | ||
| GM | 40.72% | ||
| FCFM | 10.93% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
ROICexc(3y)10.78%
ROICexc(5y)10.01%
ROICexgc(3y)18.74%
ROICexgc(5y)19.36%
ROCE(3y)12.01%
ROCE(5y)11.18%
ROICexcg growth 3Y10.29%
ROICexcg growth 5Y0.39%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.99%
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
F-Score7
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.06 | ||
| Debt/EBITDA | 0.61 | ||
| Cap/Depr | 71.76% | ||
| Cap/Sales | 1.72% | ||
| Interest Coverage | 14.58 | ||
| Cash Conversion | 66.27% | ||
| Profit Quality | 79.06% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 8.06 |
F-Score7
WACC10.12%
ROIC/WACC1.3
Cap/Depr(3y)93.58%
Cap/Depr(5y)79.88%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.41%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.93%
EPS Next Y9.69%
EPS Next 2Y11.12%
EPS Next 3Y11.07%
EPS Next 5Y12.23%
Revenue 1Y (TTM)14.45%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.36%
Revenue Next Year5.66%
Revenue Next 2Y6%
Revenue Next 3Y5.8%
Revenue Next 5Y6.72%
EBIT growth 1Y25.37%
EBIT growth 3Y17.08%
EBIT growth 5Y-5.09%
EBIT Next Year24.12%
EBIT Next 3Y14.77%
EBIT Next 5Y12.55%
FCF growth 1Y28.45%
FCF growth 3Y-20.47%
FCF growth 5Y-6.44%
OCF growth 1Y22.32%
OCF growth 3Y-18.53%
OCF growth 5Y-7.3%